This HTML5 document contains 96 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80080008
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в серпні 2006 im August 2006 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'agostu de 2006 scientific article published on 01 August 2006
p:P577
wds:Q80080008-1E6447D3-2273-4EA9-819C-906CD725BEEC
wdt:P577
2006-08-01T00:00:00Z
p:P2888
wds:Q80080008-8591CF53-5B2C-43AE-80BC-1CC9050D8C37
wdt:P2888
n11:s00432-006-0132-6
p:P2860
wds:Q80080008-2079F13C-632E-4376-95D4-AD258B639116 wds:Q80080008-21C2896D-24DD-4884-875B-D092E2B78A5B wds:Q80080008-2CB37F1E-D063-4654-B2D6-696503E96769 wds:Q80080008-377713D6-51AE-4E4E-97B2-2C2EC8222E6F wds:Q80080008-4E67B1F3-1307-49FF-9946-7A7F8D3116D0 wds:Q80080008-52CCF7F0-FF71-40D9-8FF1-7A1BC49A9F77 wds:Q80080008-5D2F371E-D593-49B7-8D2C-51D7A1A66F22 wds:Q80080008-725AD6CC-A527-4A82-AE09-122FEA715770 wds:Q80080008-7A836C57-2DAA-43BC-8CAD-B488ABA649C3 wds:Q80080008-83B8AC6E-1494-4C52-B596-89C4AB79A231 wds:Q80080008-856898D9-749D-4FB9-AD3F-FF9D2F730F57 wds:Q80080008-04A0EC08-76B6-4E46-A3EF-D3A49A98EAB5 wds:Q80080008-1D55A445-4E83-4C65-8918-AC9CE3D0933F wds:Q80080008-86F99359-A70A-4173-8B4E-DE3259935254 wds:Q80080008-8D7A8A4F-1472-466E-9B98-D4524A74D330 wds:Q80080008-A1865CD1-59C4-4C89-8751-7E9650431870 wds:Q80080008-A33D420D-777F-4C70-BB1C-D83E4045AD43 wds:Q80080008-AB1E0364-7389-4C7E-AB5C-46EA82E12CC8 wds:Q80080008-B823E173-7F06-4653-99BA-9A040DAB43E2 wds:Q80080008-D11675EA-E2A1-4821-B5E5-D3DA43ECECC9 wds:Q80080008-D32B412A-731B-4F59-9922-A5BAEA026A45 wds:Q80080008-DC78ED57-5C4D-45DE-9D2F-3C13B9B8121A wds:Q80080008-DE4D516E-C0BC-4402-BEC1-FDC34205C034 wds:Q80080008-EB1F1B26-573F-453C-9D6B-E53F4E7980B8 wds:Q80080008-F1DACEF8-3B1F-4D84-85BF-201939A1A4F1 wds:Q80080008-F423FA26-DAB3-41A3-90BF-970AFC2F53AB wds:Q80080008-F8B3C38D-0D40-4BF1-9C68-C8C8A522642E
wdt:P2860
wd:Q78703821 wd:Q31011194 wd:Q44958689 wd:Q45148605 wd:Q77876291 wd:Q35204620 wd:Q46434810 wd:Q45930559 wd:Q73941796 wd:Q41739292 wd:Q40601019 wd:Q30743682 wd:Q44895150 wd:Q46465649 wd:Q43749401 wd:Q33920850 wd:Q44070350 wd:Q45068486 wd:Q34140306 wd:Q34389536 wd:Q28140656 wd:Q34487137 wd:Q43921050 wd:Q35063675 wd:Q33800964 wd:Q44883463 wd:Q46798950
p:P2093
wds:Q80080008-073B935D-8605-405E-BDB8-384100A93AD1 wds:Q80080008-02E3776F-57D9-4631-BAC1-31400DFA819D wds:Q80080008-34766FA3-2C74-4DDE-9FDF-B9676D8C44BB
wdt:P2093
CASODEX Early Prostate Cancer Trialists' Group Chris J Tyrrell William A See
rdfs:label
The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer
skos:prefLabel
The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer
schema:name
The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer
p:P1476
wds:Q80080008-5E840772-DB44-4BB1-9D73-FEFDEFA0EE4B
wdt:P1476
The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer
p:P304
wds:Q80080008-6D2FD987-17C6-48AA-A34C-98F555166DDB
wdt:P304
S7-16
p:P31
wds:Q80080008-AC63845C-A00F-41B4-8883-9DC74B2CA335
wdt:P31
wd:Q13442814
p:P921
wds:Q80080008-B97B256A-3F76-4391-8409-8D21932CB00E wds:Q80080008-0FAA1A7A-7469-451B-B449-EC95C5CA55E8
wdt:P921
wd:Q1988832 wd:Q181257
p:P698
wds:Q80080008-0C89DF91-8CE9-4D35-A466-4AAF8B1FFE83
wdtn:P698
n12:16896884
wdt:P698
16896884
p:P1433
wds:Q80080008-F912D675-B088-4BBF-914D-E4A493D1C03C
wdt:P1433
wd:Q2081599
p:P478
wds:Q80080008-70A0345F-2DFD-4A1F-AD25-AD142AD2FC7B
wdt:P478
132 Suppl 1
p:P356
wds:Q80080008-1FD3BCA6-CC0D-45ED-8A5A-8F33EB6FAE89
wdtn:P356
n9:S00432-006-0132-6
wdt:P356
10.1007/S00432-006-0132-6